Literature DB >> 10529324

Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. A substudy of the hirudin for improvement of thrombolysis (HIT)-4 study.

R Schröder1, U Zeymer, K Wegscheider, K L Neuhaus.   

Abstract

AIMS: Previous studies revealed that >/=70% or <30% ST segment elevation resolution 180 min after the start of thrombolysis is a strong predictor of either favourable or poor outcome. The aim of this study was to compare the prognostic value of ST segment elevation resolution at 90 and 180 min after the start of streptokinase infusion. METHODS AND
RESULTS: The Hirudin for Improvement of Thrombolysis (HIT)-4 study of 1208 patients compared streptokinase therapy in conjunction with either r-hirudin or heparin. Complete ST segment elevation resolution (>/=70%) at 90 and 180 min identified 25% and 50%, respectively, of all patients with a 30 day cardiac mortality of less than 2%. Forty-four percent of patients had no ST segment elevation resolution (<30%) at 90 min and the 30 day cardiac mortality was 7.3%. At 180 min, the no ST segment elevation resolution group decreased to 15% of all patients while the mortality risk increased to 13.6%.
CONCLUSIONS: ST segment elevation resolution is a useful tool for early risk stratification and the strategy of rescue angioplasty. Complete ST segment elevation resolution within 180 min of the start of streptokinase therapy indicates excellent survival prospects in 50% of patients. A half of these low risk patients can be identified at 90 min. A high risk group appears to be best characterized by no ST segment elevation resolution at 180 min rather than at 90 min.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529324     DOI: 10.1053/euhj.1999.1664

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  14 in total

Review 1.  The use of the electrocardiogram to identify epicardial coronary and tissue reperfusion in acute myocardial infarction.

Authors:  M Vaturi; Y Birnbaum
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

2.  [Prediction of outcome in ST elevation myocardial infarction by the extent of ST segment deviation recovery. Which method is best?].

Authors:  K Schröder; U Zeymer; W Wegschneider; R Schröder
Journal:  Z Kardiol       Date:  2004-08

Review 3.  Glycoprotein IIb/IIIa receptor inhibitors in acute ST-elevation myocardial infarction: will the combination with thrombolytics become reality?

Authors:  Uwe Zeymer
Journal:  J Thromb Thrombolysis       Date:  2003-04       Impact factor: 2.300

4.  Impact of ST-segment resolution on clinical outcome in patients with ST-segment elevation myocardial infarction and preserved left ventricular function.

Authors:  Ahmed Bendary; Wael Tawfeek; Mohamed Mahros; Mohamed Salem
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-06-01       Impact factor: 1.468

5.  Resolution of ST-segment elevation in acute myocardial infarction--early prognostic significance after thrombolytic therapy. Results from the COBALT trial.

Authors:  J Carlsson; U Kamp; D Härtel; J Brockmeier; R Meierhenrich; S Miketic; S Walter; F van de Werf; U Tebbe
Journal:  Herz       Date:  1999-10       Impact factor: 1.443

Review 6.  [Patency, perfusion and prognosis in acute myocardial infarct].

Authors:  U Zeymer; R Schröder; K L Neuhaus
Journal:  Herz       Date:  1999-10       Impact factor: 1.443

7.  [Prognostic significance of ST segment change in acute myocardial infarct].

Authors:  K Wegscheider; K L Neuhaus; R Dissmann; U Tebbe; U Zeymer; R Schröder
Journal:  Herz       Date:  1999-08       Impact factor: 1.443

8.  Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial.

Authors:  Uwe Zeymer; Hans-Richard Arntz; Bernd Mark; Stephan Fichtlscherer; Gerald Werner; Ralph Schöller; Ralf Zahn; Frank Diller; Harald Darius; Thorsten Dill; Kurt Huber
Journal:  Clin Res Cardiol       Date:  2011-12-21       Impact factor: 5.460

9.  Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS).

Authors:  Hendrik-Jan Dieker; Elvira V van Horssen; Ferry M R J Hersbach; Marc A Brouwer; Ad J van Boven; Arnoud W J van 't Hof; Wim R M Aengevaeren; Freek W A Verheugt; Frits W H M Bär
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

10.  Continuous ST-segment monitoring of patients with right bundle branch block and suspicion of acute myocardial Infarction.

Authors:  Gunnar Gunnarsson; Peter Eriksson; Mikael Dellborg
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-04       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.